Compare · CBOE vs CELG~
CBOE vs CELG~
Side-by-side comparison of Cboe Global Markets, Inc. (CBOE) and Celgene Corporation (CELG~): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBOE and CELG~ operate in n/a (n/a), so they compete in similar markets.
- CBOE carries a market cap of $13.01B.
- CBOE has hit the wire 3 times in the past 4 weeks while CELG~ has been quiet.
- CBOE has more recent analyst coverage (25 ratings vs 0 for CELG~).
Cboe Global Markets, Inc.
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Latest CBOE
- Cboe Announces Agreement to Sell Cboe Australia and Cboe Canada to TMX Group
- Keefe Bruyette resumed coverage on Cboe Global Markets with a new price target
- Cboe Global Markets Reports Trading Volume for March 2026
- SEC Form DEF 14A filed by Cboe Global Markets, Inc.
- Cboe and CNBC Launch Multi-Year Collaboration to Deliver Daily Live Market Coverage from Chicago Trading Floor
- Amendment: SEC Form SCHEDULE 13G/A filed by Cboe Global Markets, Inc.
- Cboe Global Markets Announces Date of First-Quarter 2026 Earnings Release and Conference Call
- Cboe Files Proposal with the SEC to Launch Near 24x5 U.S. Equities Trading
- SEC Form 3 filed by new insider Johnston Scott L
- Cboe to Launch BITVX, A New Volatility Index Based on IBIT Options
Latest CELG~
- FDA Approval for REBLOZYL issued to CELGENE CORP
- FDA Approval for REBLOZYL issued to CELGENE CORP
- FDA Approval for REBLOZYL issued to CELGENE CORP
- FDA Approval for IDHIFA issued to CELGENE CORP
- March 27, 2021 - FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
- Sutro Biopharma Announces Appointment of Jon M. Wigginton, M.D., to Board of Directors
- Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer
- Global Stem Cells Market is estimated to account for US$ 18,289.9 Mn by end of 2027, Says Coherent Market Insights (CMI)